Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06161012 · ClinicalTrials.gov registry record · NA
Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of Wear
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 67
- Enrollment target
NCT06161012 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 67 participants.
The verdict
NCT06161012, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
Study Summary
This will be a multi-site, bilateral, dispensing, randomized, controlled, double-masked, 2×2 crossover study to evaluate ocular physiological response.
Interventions
- DEVICE Senofilcon A contact lenses (TEST)
- DEVICE Delefilcon A contact lenses (CONTROL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2023-11-16 |
| Est. Completion | 2024-02-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06161012
The ClinicalTrials.gov registry entry for NCT06161012 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Senofilcon A contact lenses (TEST) is the first listed.
NCT06161012 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06161012 about?
NCT06161012 is a clinical study titled "Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of Wear". This will be a multi-site, bilateral, dispensing, randomized, controlled, double-masked, 2×2 crossover study to evaluate ocular physiological response.
What is the current status of trial NCT06161012?
This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2023-11-16. Estimated completion is 2024-02-13.
What interventions are being tested in trial NCT06161012?
The interventions under investigation include: Senofilcon A contact lenses (TEST) (DEVICE), Delefilcon A contact lenses (CONTROL) (DEVICE).
Who is sponsoring clinical trial NCT06161012?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.